{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:24:40Z","timestamp":1790267080007,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ecl.2022.04.003","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:47:54Z","timestamp":1663807674000},"page":"741-753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Quality of Life in Patients with Adrenal Insufficiency"],"prefix":"10.1016","volume":"51","author":[{"given":"Dingfeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ecl.2022.04.003_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-021-00252-7","article-title":"Adrenal insufficiency","volume":"7","author":"Hahner","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ecl.2022.04.003_bib2","doi-asserted-by":"crossref","first-page":"n1380","DOI":"10.1136\/bmj.n1380","article-title":"Glucocorticoid induced adrenal insufficiency","volume":"374","author":"Prete","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.003_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cen.13719","article-title":"Quality of life in patients with adrenal disease: A systematic review","volume":"89","author":"Ho","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ecl.2022.04.003_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"4 Suppl","key":"10.1016\/j.ecl.2022.04.003_bib5","first-page":"AS264","article-title":"Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study","volume":"33","author":"Ware","year":"1995","journal-title":"Med Care"},{"key":"10.1016\/j.ecl.2022.04.003_bib6","series-title":"SF-36 physical & mental health summary scales: a manual for users of version 1","author":"Ware","year":"2001"},{"issue":"5","key":"10.1016\/j.ecl.2022.04.003_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1012552211996","article-title":"Do SF-36 summary component scores accurately summarize subscale scores?","volume":"10","author":"Taft","year":"2001","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ecl.2022.04.003_bib8","series-title":"User's manual for the SF-12v2TM health survey:(with a supplement documenting SF-12 health survey)","author":"Ware","year":"2007"},{"issue":"6","key":"10.1016\/j.ecl.2022.04.003_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EJE-08-0578","article-title":"Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens","volume":"159","author":"Bleicken","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.003_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2265.2009.03596.x","article-title":"Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency","volume":"72","author":"Bleicken","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ecl.2022.04.003_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MAJ.0b013e3181db6b7a","article-title":"Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients","volume":"339","author":"Bleicken","year":"2010","journal-title":"Am J Med Sci"},{"issue":"7","key":"10.1016\/j.ecl.2022.04.003_bib12","doi-asserted-by":"crossref","first-page":"e2469","DOI":"10.1210\/clinem\/dgab334","article-title":"The impact of the COVID-19 pandemic on self-reported outcomes in patients with adrenal insufficiency","volume":"106","author":"Li","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2022.04.003_bib13","article-title":"Quality of life and its determinants in patients with adrenal insufficiency: a survey study at three centers in the USA","volume":"29","author":"Li","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.003_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1210\/jc.2009-1711","article-title":"Development of a disease-specific quality of life questionnaire in Addison's disease","volume":"95","author":"Lovas","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.003_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/jc.2011-1901","article-title":"Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL","volume":"97","author":"Oksnes","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2022.04.003_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/EJE-14-1114","article-title":"Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency","volume":"172","author":"Quinkler","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2022.04.003_bib17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s40618-020-01422-2","article-title":"Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study","volume":"44","author":"Martino","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.003_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/EC-17-0368","article-title":"Dual-release hydrocortisone treatment: glycometabolic profile and health-related quality of life","volume":"7","author":"Mongioi","year":"2018","journal-title":"Endocr Connect"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.003_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2022.04.003_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-17-0067","article-title":"Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study","volume":"176","author":"Nilsson","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2022.04.003_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2265.2002.01466.x","article-title":"Subjective health status in Norwegian patients with Addison's disease","volume":"56","author":"Lovas","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.ecl.2022.04.003_bib22","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2022.04.003_bib23","doi-asserted-by":"crossref","first-page":"718660","DOI":"10.3389\/fendo.2021.718660","article-title":"Sex-specific limitations in physical health in primary adrenal insufficiency","volume":"12","author":"Didriksen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"10.1016\/j.ecl.2022.04.003_bib24","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1210\/jc.2007-0685","article-title":"Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis","volume":"92","author":"Hahner","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.003_bib25","doi-asserted-by":"crossref","first-page":"e1408","DOI":"10.1210\/clinem\/dgaa668","article-title":"Determinants of self-reported health outcomes in adrenal insufficiency: a multisite survey study","volume":"106","author":"Li","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.003_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2005-1058","article-title":"Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission","volume":"91","author":"Lindsay","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2022.04.003_bib27","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","article-title":"Quality of life in patients after long-term biochemical cure of Cushing's disease","volume":"90","author":"van Aken","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2022.04.003_bib28","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1210\/jc.2006-0676","article-title":"Quality of life in treated patients with acromegaly","volume":"91","author":"Kauppinen-Makelin","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.003_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/eje.1.02114","article-title":"Quality of life in treated adult craniopharyngioma patients","volume":"154","author":"Dekkers","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2022.04.003_bib30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11102-015-0636-7","article-title":"Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies","volume":"18","author":"Andela","year":"2015","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.ecl.2022.04.003_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-12-0308","article-title":"Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?","volume":"167","author":"Wagenmakers","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.003_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/cen.14405","article-title":"Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatment","volume":"94","author":"Sagar","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ecl.2022.04.003_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/EJE-17-0251","article-title":"Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis","volume":"177","author":"Borresen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2022.04.003_bib34","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/rheumatology\/keaa011","article-title":"Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach","volume":"59","author":"Borresen","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.003_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semarthrit.2016.03.001","article-title":"Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review","volume":"46","author":"Joseph","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.003_bib36","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/S2665-9913(20)30389-1","article-title":"Variability in counselling for adrenal insufficiency in COVID-19 and beyond: a survey of rheumatology practice","volume":"3","author":"Mehta","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.003_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/EJE-09-0170","article-title":"Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study","volume":"161","author":"Johannsson","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.003_bib38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12020-015-0681-z","article-title":"Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease","volume":"51","author":"Giordano","year":"2016","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.ecl.2022.04.003_bib39","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/cen.12316","article-title":"An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure","volume":"80","author":"Whitaker","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ecl.2022.04.003_bib40","first-page":"1797","article-title":"Modified-release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia","volume":"102","author":"Jones","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.003_bib41","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2014-3809","article-title":"A\u00a0phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia","volume":"100","author":"Mallappa","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2022.04.003_bib42","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1210\/jc.2014-2433","article-title":"Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.003_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-07-0052","article-title":"Continuous subcutaneous hydrocortisone infusion in Addison's disease","volume":"157","author":"Lovas","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2022.04.003_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/cen.13813","article-title":"Long-term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia","volume":"89","author":"Mallappa","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.ecl.2022.04.003_bib45","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/jc.2013-4253","article-title":"Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial","volume":"99","author":"Oksnes","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.003_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10484-009-9082-5","article-title":"Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study","volume":"34","author":"Harbeck","year":"2009","journal-title":"Appl Psychophysiol Biofeedback"},{"issue":"6","key":"10.1016\/j.ecl.2022.04.003_bib47","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1159\/000442985","article-title":"Hydrocortisone dose influences pain, depressive symptoms and perceived health in adrenal insufficiency: a randomized controlled trial","volume":"103","author":"Werumeus Buning","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ecl.2022.04.003_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.psyneuen.2015.02.001","article-title":"The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial","volume":"55","author":"Werumeus Buning","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.003_bib49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eprac.2021.09.011","article-title":"Secondary adrenal insufficiency: recent updates and new directions for diagnosis and management","volume":"28","author":"Gruber","year":"2022","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.ecl.2022.04.003_bib50","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/jc.2009-0032","article-title":"The approach to the adult with newly diagnosed adrenal insufficiency","volume":"94","author":"Arlt","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2022.04.003_bib51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/07435800009048561","article-title":"DHEA replacement in women with adrenal insufficiency--pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition","volume":"26","author":"Arlt","year":"2000","journal-title":"Endocr Res"},{"issue":"12","key":"10.1016\/j.ecl.2022.04.003_bib52","first-page":"4650","article-title":"Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial","volume":"85","author":"Hunt","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.003_bib53","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2007-1134","article-title":"Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial","volume":"93","author":"Gurnell","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2022.04.003_bib54","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1210\/jc.2009-0672","article-title":"A\u00a0systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency","volume":"94","author":"Alkatib","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2022.04.003_bib55","first-page":"847","article-title":"Liquid chromatographic determination of dehydroepiandrosterone (DHEA) in dietary supplement products","volume":"83","author":"Thompson","year":"2000","journal-title":"J\u00a0AOAC Int"},{"key":"10.1016\/j.ecl.2022.04.003_bib56","article-title":"Should DHEA be administered to women?","volume":"7","author":"Wierman","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.003_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ando.2014.11.004","article-title":"An observational study on adrenal insufficiency in a French tertiary centre: real life versus theory","volume":"76","author":"Castinetti","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ecl.2022.04.003_bib58","doi-asserted-by":"crossref","first-page":"701365","DOI":"10.3389\/fendo.2021.701365","article-title":"Clinical unmet needs in the treatment of adrenal crisis: importance of the patient's perspective","volume":"12","author":"Claessen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.003_bib59","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.003_bib60","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-14-0824","article-title":"Extensive expertise in endocrinology. Adrenal crisis","volume":"172","author":"Allolio","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.003_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/cen.12865","article-title":"Incidence of adrenal crisis in patients with adrenal insufficiency","volume":"84","author":"Smans","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.003_bib62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-09-0559","article-title":"Adrenal crisis in treated Addison's disease: a predictable but under-managed event","volume":"162","author":"White","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.003_bib63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-08-0550","article-title":"Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death","volume":"160","author":"Erichsen","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.ecl.2022.04.003_bib64","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1473-3099(20)30195-X","article-title":"Real estimates of mortality following COVID-19 infection","volume":"20","author":"Baud","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ecl.2022.04.003_bib65","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-16-0969","article-title":"Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality","volume":"176","author":"Bancos","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.ecl.2022.04.003_bib66","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s40618-020-01266-w","article-title":"COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency","volume":"43","author":"Isidori","year":"2020","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.003_bib67","doi-asserted-by":"crossref","first-page":"G25","DOI":"10.1530\/EJE-20-0361","article-title":"Endocrinology in the time of Covid-19: Management of adrenal insufficiency","volume":"183","author":"Arlt","year":"2020","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852922000342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852922000342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:47:40Z","timestamp":1760176060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852922000342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0889852922000342"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2022.04.003","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life in Patients with Adrenal Insufficiency","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2022.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}